Still Kenneth R, Jederberg Warren W, Ritchie Glenn D, Rossi John
Naval Health Research Center-Detachment Toxicology (NHRC-TD), Wright-Patterson AFB, OH, USA.
Drug Chem Toxicol. 2002 Nov;25(4):383-401. doi: 10.1081/dct-120014791.
The risk assessment process is a critical function for military Deployment Toxicology research objectives, emphasizing improved health protection of deployed forces. Reliable risk assessment methodology is essential for decision making related to risk reduction procedures during combat deployment, as well as during routine occupational activities. Such decision making must be based upon quality science that both guides sound judgments in risk characterization and management, and provides necessary health protection tools. The health and fitness of deployed forces must be considered for both acute and long-term issues. Exposure assessment specifies populations that might be exposed to injurious agents, identifies routes of exposure, and estimates the magnitude, duration, and timing of the doses that personnel may receive as a result of their exposure. Acute or short-term catastrophic risks for deployed forces are of immediate concern and must be addressed on a risk prioritization basis using Operational Risk Management (ORM) procedures. However, long-term effects of exposure to the same agents must be considered as part of the overall health concerns for deployed forces. In response to these needs, a number of military, federal government, academic and private sector organizations are currently developing new classes of biologically-based biosensors with the programmed capacity to detect the presence of virtually any environmental chemical or biological stressor with the capacity to induce health consequences in deployed personnel. A major objective of this engineering effort is development of biosensor systems that detect novel (previously unresearched) chemical or biological agents that might be used during international combat or terrorist attacks to induce acute or long-term health effects on military or civilian populations. A large portion of the discussion in this paper is devoted to describing the development, testing, and implementation of tissue-based biosensors (TBBs) that utilize small samples of living tissue from laboratory small animals for a wide range of human risk assessment applications.
风险评估过程对于军事部署毒理学研究目标而言是一项关键职能,其重点在于加强对部署部队的健康保护。可靠的风险评估方法对于作战部署期间以及日常军事活动中的风险降低程序相关决策至关重要。此类决策必须基于高质量的科学,既要为风险特征描述和管理中的合理判断提供指导,又要提供必要的健康保护工具。对于部署部队的健康和体能,必须同时考虑急性和长期问题。暴露评估明确可能接触有害制剂的人群,确定暴露途径,并估计人员因暴露可能接受的剂量大小、持续时间和时间点。部署部队面临的急性或短期灾难性风险是当下的关注重点,必须使用作战风险管理(ORM)程序,按风险优先级加以应对。然而,接触相同制剂的长期影响必须作为部署部队整体健康问题的一部分加以考虑。为满足这些需求,一些军事、联邦政府、学术和私营部门组织目前正在研发新型基于生物的生物传感器,这些传感器具备编程能力,能够检测几乎任何可能对部署人员造成健康影响的环境化学或生物应激源的存在。这项工程工作的一个主要目标是开发生物传感器系统,以检测可能在国际战斗或恐怖袭击中使用的新型(此前未研究过的)化学或生物制剂,这些制剂可能对军事或平民人口造成急性或长期健康影响。本文的大部分讨论致力于描述基于组织的生物传感器(TBB)的开发、测试和实施,该传感器利用实验室小动物的少量活体组织样本,用于广泛的人类风险评估应用。